Search

Your search keyword '"Stuart, David I."' showing total 1,332 results

Search Constraints

Start Over You searched for: Author "Stuart, David I." Remove constraint Author: "Stuart, David I."
1,332 results on '"Stuart, David I."'

Search Results

1. Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification

2. Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection

4. Sample Preparation and Data Collection for High-Speed Fixed-Target Serial Femtosecond Crystallography

5. Accelerating Inhibitor Discovery With A Deep Generative Foundation Model: Validation for SARS-CoV-2 Drug Targets

7. Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam

8. A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity

14. CryoSIM: super-resolution 3D structured illumination cryogenic fluorescence microscopy for correlated ultrastructural imaging

15. Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses

16. Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region

17. A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75

18. Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

20. Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.

21. Towards in cellulo virus crystallography.

27. Risk-free polio vaccine: Recombinant expression systems for production of stabilised virus-like particles

29. High-speed fixed-target serial virus crystallography

30. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

31. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

32. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

33. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

34. Structure of CPV17 polyhedrin determined by the improved analysis of serial femtosecond crystallographic data.

35. A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses

36. Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19

39. Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19

41. COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance

42. Snapshots from Cryo-ET of active SARS-CoV-2 virions

45. Glycogen Phosphorylase b

Catalog

Books, media, physical & digital resources